CD44 and neoplasm: CD44 expression was reported to be not correlated with tumor-specific survival in 107 patients (HR = 1.52, 95% CI = 0.47–2.57) [37] and be not associated with overall survival (HR = 0.66, 95% CI = 0.2–2.1) [35] in 66 cases.